Tonix Pharmaceuticals (TNXP)
(Delayed Data from NSDQ)
$0.15 USD
0.00 (-1.60%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.14 -0.01 (-5.08%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -2.03 |
EPS Last Quarter | -19.28 |
Last EPS Surprise | -94.55% |
ABR | 1.00 |
Earnings ESP
|
-80.30% |
---|---|
Current Year | -18.00 |
Next Year | -5.54 |
EPS (TTM) | -110.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.63M | 3.05M | 10.37M | 14.83M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 2.95M | 3.80M | 11.44M | 20.15M |
Low Estimate | 2.30M | 2.30M | 9.30M | 9.50M |
Year ago Sales | 3.99M | 3.78M | 7.77M | 10.37M |
Year over Year Growth Est. | -34.21% | -19.31% | 33.50% | 42.96% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.03 | -1.84 | -18.00 | -5.54 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -3.66 | -3.45 | -34.09 | -10.46 |
High Estimate | -0.40 | -0.22 | -1.91 | -0.62 |
Low Estimate | -3.66 | -3.45 | -34.09 | -10.46 |
Year ago EPS | -58.47 | -27.48 | -218.85 | -18.00 |
Year over Year Growth Est. | 96.53% | 93.30% | 91.78% | 69.22% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 0 | 1 |
Up Last 60 Days | 2 | 2 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.03 | -1.84 | -18.00 | -5.54 |
7 Days Ago | -2.03 | -1.84 | -18.00 | -5.54 |
30 Days Ago | -2.92 | -2.83 | -13.74 | -8.30 |
60 Days Ago | -3.18 | -3.08 | -14.98 | -8.85 |
90 Days Ago | -7.03 | -6.71 | -30.51 | -19.17 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -3.66 | -3.45 | -34.09 | -10.46 |
Zacks Consensus Estimate | -2.03 | -1.84 | -18.00 | -5.54 |
Earnings ESP | -80.30% | -88.01% | -89.39% | -88.81% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -19.28 | -5.75 | -27.48 | -58.47 | NA |
Estimate | -9.91 | -16.61 | -49.84 | -47.60 | NA |
Difference | -9.37 | 10.86 | 22.36 | -10.87 | 3.25 |
Surprise | -94.55% | 65.38% | 44.87% | -22.82% | -1.78% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more